Shares of Amarin (AMRN) are up 90c, or 5.2%, to $18.33 in early trading amid rumors that Novartis (NVS) may be in talks to acquire the company. The Fly, in fulfilling its mission of explaining stock movement, often comes across the many unconfirmed rumors being passed through trading desks and social media platforms. On the occasion that rumors or speculation appear on The Fly’s news feed, it should be viewed not as giving credence to the conjecture, rather as simply highlighting its impact on the stock prices of the companies involved.
https://thefly.com/landingPageNews.php?id=2868793
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.